Page last updated: 2024-08-23

etoposide and Acid beta-Glucosidase Deficiency

etoposide has been researched along with Acid beta-Glucosidase Deficiency in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Lucari, B; Porea, T; Sutton, VR; Tallis, E1
Baltogianni, M; Bouza, H; Farmaki, E; Giapros, V; Kosmeri, C; Lianou, L; Lykopoulou, L; Makis, A; Papadakis, V; Papadopoulou, E; Rallis, D; Tzanoudaki, M1
Anderson, HE; Taylor, MRG1
Aran, JM; Gottesman, MM; Licht, T; Pastan, I1
Böhm, P; Einsele, H; Horny, HP; Kunz, W1

Reviews

1 review(s) available for etoposide and Acid beta-Glucosidase Deficiency

ArticleYear
Adult Gaucher disease in association with primary malignant bone tumors.
    Cancer, 2001, Feb-01, Volume: 91, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Male; Prednisone; Radiography; Vincristine

2001

Other Studies

4 other study(ies) available for etoposide and Acid beta-Glucosidase Deficiency

ArticleYear
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma.
    Pediatric hematology and oncology, 2023, Volume: 40, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Enzyme Therapy; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine

2023
Gaucher Disease Type 2 Manifested as Hemophagocytic Lymphohistiocytosis in a Neonate in the COVID-19 Era.
    Journal of pediatric hematology/oncology, 2023, 05-01, Volume: 45, Issue:4

    Topics: COVID-19; Etoposide; Gaucher Disease; Humans; Infant, Newborn; Lymphohistiocytosis, Hemophagocytic

2023
Consequences of treatment for hemophagocytic lymphohistiocytosis in a patient with undiagnosed Gaucher disease Type 1.
    American journal of medical genetics. Part A, 2020, Volume: 182, Issue:12

    Topics: Adult; Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Gaucher Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Osteonecrosis; Prognosis; Young Adult

2020
Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy.
    Human gene therapy, 1996, Nov-10, Volume: 7, Issue:17

    Topics: Animals; Anthracenes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Cells, Cultured; Colchicine; Cyclosporins; DNA, Complementary; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fibroblasts; Gaucher Disease; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; Glucosylceramidase; Humans; Mice; Mutagenesis, Insertional; Retroviridae; Transfection; Verapamil

1996